CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
NaCl 0.9% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06249113
NCT06249113N/ACompleted
CompareCT.gov

Effectiveness of Adjuvant Continuous Lidocaine in General Anesthesia on Depth of Anesthesia (qCON), Pain Response (qNOX), and Blood Sugar Levels in Elective Primary Tumor Craniotomy Surgery

Indonesia University·interventional·Posted Feb 8, 2024·Updated Feb 16, 2024

In Brief

A clinical study evaluating NaCl 0.9% and Adjuvant lidocaine continous for Surgery and 2 related conditions. Completed, enrolled 60 participants across 1 site.

Detailed Summary

This study aims to investigate the effect of adjuvant continuous lidocaine in General Anesthesia on Depth of Anesthesia (qCON), Pain Response (qNOX), and Blood Sugar Levels in Elective Primary Tumor Craniotomy Surgery

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSurgery, Anesthesia; Functional, Haemodynamic Instability
CountriesIndonesia
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedFeb 8, 2024
Enrollment StartJan 16, 2023
Primary CompletionNov 23, 2023
Study CompletionJan 10, 2024
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 2.4 years ago

Interventions

NaCl 0.9%drug

NaCl 0.9% continous intravenous on tumor craniotomy surgery

Adjuvant lidocaine continousdrug

Adjuvant lidocaine continous intravenous on tumor craniotomy surgery